These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8146845)

  • 1. [Hypocoagulation caused by thiabendazole-acenocoumarol interaction].
    Henri P; Mosquet B; Hurault de Ligny B; Lacotte J; Cardinau E; Moulin M; Ryckelinck JP
    Therapie; 1993; 48(5):500-1. PubMed ID: 8146845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Digestive hemorrhage caused by excessive hypocoagulation induced by interaction of piroxicam and a vitamin K antagonist].
    Desprez D; Blanc P; Larrey D; Michel H
    Gastroenterol Clin Biol; 1992; 16(11):906-7. PubMed ID: 1483568
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced anticoagulant effect of acenocoumarol induced by amiodarone coadministration.
    Caraco Y; Raveh D; Flugelman M; Raz I
    Isr J Med Sci; 1988 Nov; 24(11):688-9. PubMed ID: 3215763
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of acenocoumarol action by L-carnitine.
    Martinez E; Domingo P; Roca-Cusachs A
    J Intern Med; 1993 Jan; 233(1):94. PubMed ID: 8429297
    [No Abstract]   [Full Text] [Related]  

  • 5. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
    Wey PF; Petitjeans F; Lions C; Ould-Ahmed M; Escarment J
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):173-7. PubMed ID: 18775393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring?
    Schalekamp T; Boink GJ; Visser LE; Stricker BH; de Boer A; Klungel OH
    Clin Pharmacol Ther; 2006 Jun; 79(6):511-20. PubMed ID: 16765138
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypervitaminosis E.
    Moharana S; Moharana DN
    Indian J Physiol Pharmacol; 1999 Jul; 43(3):407-9. PubMed ID: 10776496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pulmonary hemorrhage caused by the interaction of acenocoumarin and sodium diclofenac].
    Cuadrado Gómez LM; Palau Beato E; Pérez Venegas J; Pérez Moro E
    Rev Clin Esp; 1987 Sep; 181(4):227-8. PubMed ID: 3671847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tamoxifen-acenocoumarol interaction. A potentially dangerous interaction].
    Gustovic P; Baldin B; Tricoire MJ; Chichmanian RM
    Therapie; 1994; 49(1):55-6. PubMed ID: 8091371
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible interaction between topical terbinafine and acenocoumarol.
    Morales-Molina JA; Arrebola MA; Robles PA; Mangana JC
    Ann Pharmacother; 2009 Nov; 43(11):1911-2. PubMed ID: 19843835
    [No Abstract]   [Full Text] [Related]  

  • 12. Acenocoumarol stabilization is delayed in CYP2C93 carriers.
    Schalekamp T; van Geest-Daalderop JH; de Vries-Goldschmeding H; Conemans J; Bernsen Mj Mj; de Boer A
    Clin Pharmacol Ther; 2004 May; 75(5):394-402. PubMed ID: 15116052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unintentional ingestion of a high dose of acenocoumarol in a young child.
    Brands MR; Sytema J; van Hulst M; Kamps AW
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33795273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ileus caused by the use of acenocoumarol].
    de Boer HH
    Ned Tijdschr Geneeskd; 1967 Apr; 111(15):675-8. PubMed ID: 6047044
    [No Abstract]   [Full Text] [Related]  

  • 16. Retroperitoneal haematoma in a patient treated with acenocoumarol, phenytoin and paroxetine.
    Abad-Santos F; Carcas AJ; F-Capitán C; Frias J
    Clin Lab Haematol; 1995 Jun; 17(2):195-7. PubMed ID: 8536426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of the incidence and hospital follow-up of epistaxis in patients treated with anticoagulant acenocoumarol].
    García Callejo FJ; Velert Vila MM; Orts Alborch MH; Monzó Gandía R; Pardo Mateu L; Rubio Escolano F; Marco Algarra J
    Acta Otorrinolaringol Esp; 1997; 48(5):358-62. PubMed ID: 9376156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.
    Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH
    Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable interaction between citalopram and acenocoumarol.
    Borrás-Blasco J; Marco-Garbayo JL; Bosca-Sanleon B; Navarro-Ruiz A
    Ann Pharmacother; 2002 Feb; 36(2):345. PubMed ID: 11847961
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple drug-related exanthema caused by thiabendazole].
    Casado Jiménez M; Soto Melo J
    Actas Dermosifiliogr; 1977; 68(11-12):675-80. PubMed ID: 613742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.